Boris Petrov

Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives

N. Vassilev, T. Pencheva, V. Angelova, 2022, Antibiotics.

Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity Relationships

I. Doytchinova, N. Vassilev, Z. Zhivkova, 2023, Molecules.